Skip to content

Zinc Supplementation and Diarrhea in Children

Impact of Zinc Supplementation on Diarrhea Duration and Severity in Hospitalized Children in Ardabil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201103065989N1
Enrollment
228
Registered
2011-05-30
Start date
2005-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea. Diarrhoea and gastroenteritis of presumed infectious origin

Interventions

Intervention 1: Intervention group received 20 mg zinc sulfate in dextrose 5% daily plus their routine drugs during the hospitalization time. Intervention 2: Control group received 5 cc dextrose 5% da
Treatment - Drugs
Intervention group received 20 mg zinc sulfate in dextrose 5% daily plus their routine drugs during the hospitalization time.
Control group received 5 cc dextrose 5% daily plus their routine drugs during the hospitalization time.

Sponsors

Ardabil Uinversity of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 5 Years

Inclusion criteria

Inclusion criteria: Inclusion: Children who hospitalized with acute diarrhea Ixclusion: Children who had perior of hospitalizition and severe illness in two last months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of diarrhea. Timepoint: Number of hospitalization days were used as duratin time. Method of measurement: Number of hospitalized days.;Severity of diarrhea. Timepoint: Daily during the hospitalization time. Method of measurement: Number of defecation in day.

Secondary

MeasureTime frame
There weren't secondary outcome measure. Timepoint: There weren't secondary outcome measure. Method of measurement: There weren't secondary outcome measure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfrouz Mardi

Ardabil University of Medical Sciences

a.mardi@arums.ac.ir+98 45 1552 0477

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026